According to the research report, the global cryotherapy market size is expected to touch USD 17.18 Billion by 2032, from USD 8.4 Billion in 2022, growing with a significant CAGR of 7.42% from 2023 to 2032.
Key Takeaways:
- North America captured more than 44% of revenue share in 2022.
- By therapy type, the cryosurgery segment shows notable growth in the cryotherapy market during the forecast period.
- By device type, the cryochamber segment is expected to grow at a significant rate during the forecast period.
- By end-user, the hospitals & specialty clinics segment is expected to share the maximum CAGR during the projection period.
- By distribution channel, the hospital pharmacy segment dominated the global market.
The cryotherapy report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global cryotherapy in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global cryotherapy market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global cryotherapy during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3134
This study covers a detailed segmentation of the global cryotherapy market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global cryotherapy market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Brymill Cryogenic Systems
- Metrum Cryoflex
- Medtronic Medicale S.r.l.
- Cryoalfa
- Wallach Surgical Devices
- Zimmer M CryoConcepts LP
- Medtronic
- Cortex Technology
- edizinSysteme GmbH
- CryoConcepts LP
- Medtronic
- Cortex Technology
Market Segmentation
By Therapy Type
- Cryosurgery
- Icepack Therapy
- Chamber Therapy
By Device Type
- Tissue Spray Probes
- Gas Cylinders
- Cryogun
- Cryo Probes
- Tissue Contact Probes
- Tissue Spray Probes
- Gas Cylinders
- Localized Cryotherapy Devices
- Cryochambers
By Application
- Surgical Applications
- Oncology
- Cardiology
- Dermatology
- Cold Storage
- Pain Management
- Beauty & Wellness
- Fitness
By End-User
- Hospitals & Specialty Clinics
- Cryotherapy Centers
- Spas & Fitness Centers
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global cryotherapy report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global cryotherapy market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cryotherapy Market
5.1. COVID-19 Landscape: Cryotherapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cryotherapy Market, By Therapy Type
8.1. Cryotherapy Market, by Therapy Type, 2023-2032
8.1.1. Cryosurgery
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Icepack Therapy
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Chamber Therapy
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Cryotherapy Market, By Device Type
9.1. Cryotherapy Market, by Device Type, 2023-2032
9.1.1. Tissue Spray Probes
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Gas Cylinders
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Cryogun
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Cryo Probes
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Tissue Contact Probes
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Tissue Spray Probes
9.1.6.1. Market Revenue and Forecast (2020-2032)
9.1.7. Gas Cylinders
9.1.7.1. Market Revenue and Forecast (2020-2032)
9.1.8. Localized Cryotherapy Devices
9.1.8.1. Market Revenue and Forecast (2020-2032)
9.1.9. Cryochambers
9.1.9.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Cryotherapy Market, By Application
10.1. Cryotherapy Market, by Application, 2023-2032
10.1.1. Surgical Applications
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Cold Storage
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Pain Management
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Beauty & Wellness
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Fitness
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Cryotherapy Market, By End-User
11.1. Cryotherapy Market, by End-User, 2023-2032
11.1.1. Hospitals & Specialty Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Cryotherapy Centers
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Spas & Fitness Centers
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Cryotherapy Market, By Distribution Channel
12.1. Cryotherapy Market, by Distribution Channel, 2023-2032
12.1.1. Hospital Pharmacy
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Retail Pharmacy
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Online Pharmacy
12.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Cryotherapy Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.1.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.4. Market Revenue and Forecast, by End-User (2020-2032)
13.1.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.4. Market Revenue and Forecast, by End-User (2020-2032)
13.1.6.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.4. Market Revenue and Forecast, by End-User (2020-2032)
13.1.7.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.2.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.4. Market Revenue and Forecast, by End-User (2020-2032)
13.2.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.7. Market Revenue and Forecast, by End-User (2020-2032)
13.2.8. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.10. Market Revenue and Forecast, by End-User (2020-2032)
13.2.11. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.4. Market Revenue and Forecast, by End-User (2020-2032)
13.2.13. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.4. Market Revenue and Forecast, by End-User (2020-2032)
13.2.15. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.3.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.4. Market Revenue and Forecast, by End-User (2020-2032)
13.3.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.4. Market Revenue and Forecast, by End-User (2020-2032)
13.3.7. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.4. Market Revenue and Forecast, by End-User (2020-2032)
13.3.9. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.4. Market Revenue and Forecast, by End-User (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.4. Market Revenue and Forecast, by End-User (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.4.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.4. Market Revenue and Forecast, by End-User (2020-2032)
13.4.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.4. Market Revenue and Forecast, by End-User (2020-2032)
13.4.7. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.4. Market Revenue and Forecast, by End-User (2020-2032)
13.4.9. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.4. Market Revenue and Forecast, by End-User (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.4. Market Revenue and Forecast, by End-User (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.5.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.4. Market Revenue and Forecast, by End-User (2020-2032)
13.5.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.4. Market Revenue and Forecast, by End-User (2020-2032)
13.5.7. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Therapy Type (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Device Type (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.4. Market Revenue and Forecast, by End-User (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
Chapter 14. Company Profiles
14.1. Brymill Cryogenic Systems
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Metrum Cryoflex
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Medtronic Medicale S.r.l.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Cryoalfa
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Wallach Surgical Devices
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Zimmer M CryoConcepts LP
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Medtronic
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Cortex Technology
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. edizinSysteme GmbH
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. CryoConcepts LP
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments